Dachaigh › Cairtean uaine › Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.: sponsorachadh cairt uaine (PERM)
Chuir Sumitomo Pharma America, Inc. 3 iarrtasan dearbhaidh obrach PERM a chaidh a dhearbhadh ann am bliadhnaichean ionmhais 2024–2026; dearbhte: 3. Tuarastal meadhanach tairgte $163,238; ùine mheadhanach bhon chur-a-steach chun dearbhadh: 520 làithean.
Tuarastalan H-1B aig Sumitomo Pharma America, Inc. →
Tiotalan dreuchd
| Tiotal dreuchd | Iarrtasan PERM | Tuarastal meadhanach |
|---|---|---|
| Senior Manager, Digital Innovator | 1 | $163,238 |
| Associate Director, Clinical Intelligence | 1 | $163,238 |
| Director, Market Access Marketing (Multiple Openings) | 1 | $200,000 |
Làraich obrach
Gnìomhan
Co-dhùnaidhean as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Air a cho-dhùnadh | Inbhe | Làithean |
|---|---|---|---|---|---|---|
| Director, Market Access Marketing (Multiple Openings) | $200,000–$230,000 | Marlborough, MA | 11 Màrt 2025 | 29 Cèit 2026 | Dearbhte | 444 |
| Senior Manager, Digital Innovator | $163,238–$244,300 | New York, NY | 23 Sult 2024 | 25 Gearr 2026 | Dearbhte | 520 |
| Associate Director, Clinical Intelligence | $163,238–$209,500 | New York, NY | 20 Sult 2024 | 25 Gearr 2026 | Dearbhte | 523 |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; bidh na staitistigean a’ cleachdadh iarrtasan làn-ùine teisteanasach. Is e teisteanas PERM aon cheum a dh’ionnsaigh caird-uaine; bidh USCIS a’ co-dhùnadh an ath-thagraidh. Chan e comhairle laghail a th’ ann. Stòr: Roinn Obrach nan SA, Dàta Foillseachaidh OFLC PERM, bliadhnaichean ionmhais 2024–2026 (co-dhùnadh as ùire 30 Ògmh 2026).